High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma - Reply Journal Article

  

Authors:	Altundag, K.; Altundag, O.; Morandi, P.; Gunduz, M.; Morris, M. J.; Scher, H. I.; Sauter, N.
Article Title:	High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma - Reply
Keywords:	platelet derived growth factor; somatomedin; treatment outcome; osteolysis; clinical trial; advanced cancer; drug megadose; letter; adenocarcinoma; apoptosis; bone morphogenetic protein; transforming growth factor beta; antineoplastic combined chemotherapy protocols; dexamethasone; calcitriol; angiogenesis; prostatic neoplasms; disease progression; prostaglandin; breast carcinoma; interleukin 6; phase 1 clinical trial; tumor growth; cytokine release; cell adhesion; parathyroid hormone; diphosphonates; fibroblast growth factor; zoledronic acid; imidazoles; osteoclast differentiation factor; prostate carcinoma; humans; human; male; priority journal
Journal Title:	Cancer
Volume:	101
Issue:	5
ISSN:	0008-543X
Publisher:	Wiley Blackwell
Date Published:	2004-09-01
Start Page:	1101
End Page:	1103
Language:	English
PUBMED:	15329924
PROVIDER:	scopus
DOI:	10.1002/cncr.20459
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-4143117958&partnerID=40&md5=f426767cb8e583d7cb6ac7429df3a78a
Notes:	Cited By (since 1996):1 -- Export Date: 16 June 2014 -- CODEN: CANCA -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/54816